129 related articles for article (PubMed ID: 25257351)
1. The influence of enalapril and spironolactone on electrolyte concentrations in Doberman pinschers with dilated cardiomyopathy.
Thomason JD; Rapoport G; Fallaw T; Calvert CA
Vet J; 2014 Dec; 202(3):573-7. PubMed ID: 25257351
[TBL] [Abstract][Full Text] [Related]
2. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
Thomason JD; Rockwell JE; Fallaw TK; Calvert CA
J Vet Cardiol; 2007 Nov; 9(2):103-8. PubMed ID: 17983885
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of benazepril hydrochloride to delay the progression of occult dilated cardiomyopathy in Doberman Pinschers.
O'Grady MR; O'Sullivan ML; Minors SL; Horne R
J Vet Intern Med; 2009; 23(5):977-83. PubMed ID: 19572914
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil.
Saito M; Nakayama D; Takada M; Hirooka K; Yasumura Y
J Clin Pharm Ther; 2006 Dec; 31(6):535-40. PubMed ID: 17176359
[TBL] [Abstract][Full Text] [Related]
5. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy.
O'Grady MR; Minors SL; O'Sullivan ML; Horne R
J Vet Intern Med; 2008; 22(4):897-904. PubMed ID: 18537880
[TBL] [Abstract][Full Text] [Related]
6. Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs.
Schuller S; Van Israël N; Vanbelle S; Clercx C; McEntee K
J Vet Pharmacol Ther; 2011 Aug; 34(4):322-31. PubMed ID: 20950346
[TBL] [Abstract][Full Text] [Related]
7. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
[TBL] [Abstract][Full Text] [Related]
8. Prospective clinical trial evaluating spironolactone in Doberman pinschers with congestive heart failure due to dilated cardiomyopathy.
Laskary A; Fonfara S; Chambers H; O'Sullivan ML
J Vet Cardiol; 2022 Apr; 40():84-98. PubMed ID: 34315691
[TBL] [Abstract][Full Text] [Related]
9. ACE inhibitor co-therapy in patients with heart failure: rationale for the Randomized Aldactone Evaluation Study (RALES).
Pitt D
Eur Heart J; 1995 Dec; 16 Suppl N():107-10. PubMed ID: 8682055
[TBL] [Abstract][Full Text] [Related]
10. Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.
Epstein M; Williams GH; Weinberger M; Lewin A; Krause S; Mukherjee R; Patni R; Beckerman B
Clin J Am Soc Nephrol; 2006 Sep; 1(5):940-51. PubMed ID: 17699311
[TBL] [Abstract][Full Text] [Related]
11. Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group. The COVE Study Group.
J Vet Intern Med; 1995; 9(4):243-52. PubMed ID: 8523321
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of enalapril and spironolactone in hamsters with dilated cardiomyopathy.
Goineau S; Pape D; Guillo P; Ramée MP; Bellissant E
J Cardiovasc Pharmacol; 2003 Jan; 41(1):49-59. PubMed ID: 12500021
[TBL] [Abstract][Full Text] [Related]
13. Safety of spironolactone in dogs with chronic heart failure because of degenerative valvular disease: a population-based, longitudinal study.
Lefebvre HP; Ollivier E; Atkins CE; Combes B; Concordet D; Kaltsatos V; Baduel L
J Vet Intern Med; 2013; 27(5):1083-91. PubMed ID: 23869534
[TBL] [Abstract][Full Text] [Related]
14. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group.
Ettinger SJ; Benitz AM; Ericsson GF; Cifelli S; Jernigan AD; Longhofer SL; Trimboli W; Hanson PD
J Am Vet Med Assoc; 1998 Dec; 213(11):1573-7. PubMed ID: 9838955
[TBL] [Abstract][Full Text] [Related]
15. Use of spironolactone in heart failure patients receiving angiotensin-converting enzyme inhibitors and beta-blockers.
Ahmed A
J Am Coll Cardiol; 2003 May; 41(10):1851-2. PubMed ID: 12767683
[No Abstract] [Full Text] [Related]
16. Influence of antiarrhythmia therapy on survival times of 19 clinically healthy Doberman pinschers with dilated cardiomyopathy that experienced syncope, ventricular tachycardia, and sudden death (1985-1998).
Calvert CA; Brown J
J Am Anim Hosp Assoc; 2004; 40(1):24-8. PubMed ID: 14736902
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 10 genes encoding cardiac proteins in Doberman Pinschers with dilated cardiomyopathy.
O'Sullivan ML; O'Grady MR; Pyle WG; Dawson JF
Am J Vet Res; 2011 Jul; 72(7):932-9. PubMed ID: 21728854
[TBL] [Abstract][Full Text] [Related]
18. Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin-angiotensin system blockers: a UK primary care cohort study.
Sinnott SJ; Mansfield KE; Schmidt M; Bhaskaran K; Smeeth L; Nitsch D; Tomlinson LA
BMJ Open; 2017 Nov; 7(11):e018153. PubMed ID: 29150471
[TBL] [Abstract][Full Text] [Related]
19. Association between results of ambulatory electrocardiography and development of cardiomyopathy during long-term follow-up of Doberman pinschers.
Calvert CA; Jacobs GJ; Smith DD; Rathbun SL; Pickus CW
J Am Vet Med Assoc; 2000 Jan; 216(1):34-9. PubMed ID: 10638315
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
